Your browser doesn't support javascript.
loading
Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution.
Haas, Joel T; Vonghia, Luisa; Mogilenko, Denis A; Verrijken, An; Molendi-Coste, Olivier; Fleury, Sébastien; Deprince, Audrey; Nikitin, Artemii; Woitrain, Eloïse; Ducrocq-Geoffroy, Lucie; Pic, Samuel; Derudas, Bruno; Dehondt, Hélène; Gheeraert, Céline; Van Gaal, Luc; Driessen, Ann; Lefebvre, Philippe; Staels, Bart; Francque, Sven; Dombrowicz, David.
Afiliação
  • Haas JT; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Vonghia L; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium. luisa.vonghia@uza.be.
  • Mogilenko DA; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. luisa.vonghia@uza.be.
  • Verrijken A; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Molendi-Coste O; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Fleury S; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
  • Deprince A; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Nikitin A; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Woitrain E; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Ducrocq-Geoffroy L; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Pic S; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Derudas B; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Dehondt H; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Gheeraert C; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Van Gaal L; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Driessen A; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Lefebvre P; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Staels B; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
  • Francque S; Department of Pathology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
  • Dombrowicz D; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
Nat Metab ; 1(7): 744, 2019 Jul.
Article em En | MEDLINE | ID: mdl-32694642
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article